孟鲁司特联合沙美特罗替卡松治疗218例支气管炎哮喘的可行性探究

The Feasibility Study of the Treatment of 218 Cases of Bronchitis Asthma by Montelukast Combined with Salmeterol

目的探讨孟鲁司特联合沙美特罗替卡松治疗支气管炎哮喘临床疗效。方法选取218例支气管炎患者作为研究对象,分为观察组对照组,各109例。观察组采用孟鲁斯特联合沙美特罗替卡松;对照组采用沙美特罗替卡松。比较两组肺功能情况和不良反应情况。结果观察组治疗有效率为94.4%,对照组为82.6%,差异具有统计学意义(P<0.05)。观察组治疗后肺功能改善情况优于对照组。结论采用孟鲁司特联合沙美特罗替卡松治疗支气管炎哮喘具有临床效果。

Objective To study clinical curative effect of montelukast combined with Shah Mette Lo Tikason to treat bronchitis asthma.MethodsTo choose 218 cases of bronchitis patients as the research object.They were divided into the observation group and the control group.The observation group treated with meng LuSi combined with salmeterol. The control group used salmeterol .Results The observation group treatment effective rate was 94.4%,the control group was 82.6%,and the difference statisticaly significant（P 〈 0.05）.Conclusion The meng LuSi combined with salmeterol for treatment of bronchitis asthma is worthy of popularization and application.